Knight Therapeutics Inc. updated revenue guidance for fiscal 2022. For the year company has updated its guidance and expects to generate $265 to $275 million in revenue, an increase of $5 million on the lower and upper range.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6 CAD | +0.67% | -1.80% | +15.61% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.61% | 445M | |
+16.41% | 79.16B | |
+8.35% | 8.72B | |
-16.83% | 4.79B | |
+47.36% | 4.62B | |
+1.74% | 3.82B | |
+14.51% | 2.33B | |
-26.23% | 2.2B | |
+15.63% | 2.1B | |
-34.87% | 2.04B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics Inc. Updates Revenue Guidance for Fiscal 2022